what are glp 1 meds The GLP-1 revolution: UAB researchers discovering about how these drugs work How GLP-1 medications are transforming

Rivera FB, Cruz LLA, Magalong JV et al (2024) Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

Further, analyses could also be conducted on the possible relationship between GLP-1 RAs use and serum thyroglobulin (Tg) levels, as some studies have shown that Tg correlates with abnormal thyroid function and thyroid volume [63]

Unfortunately, some of them have been seen to last months or years after the patient stop the use

Application (Type 2 Diabetes, Weight Loss)

In the additional analysis comparing the GLP1 receptor agonist group with the SGLT2 inhibitor group, the hazard ratio for thyroid cancer was 1.16

[DOI] [PubMed] [Google Scholar] 732.Bernstein I.L., Chavez M., Allen D., Taylor E.M